• 1. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 2. Evolution study of photo-synthesized gold nanoparticles by spectral deconvolution model: a quantitative approach
  Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735
• 3. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 4. Exceptionally high temperature spin crossover in amide-functionalised 2,6-bis(pyrazol-1-yl)pyridine iron(ii) complex revealed by variable temperature Raman spectroscopy and single crystal X-ray diffraction?
  Max Attwood,Hiroki Akutsu,Lee Martin,Toby J. Blundell,Pierre Le Maguere,Scott S. Turner Dalton Trans., 2021,50, 11843-11851
• 5. Dissociative electron attachment to HGaF4 Lewis–Br?nsted superacid
  Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Phenylphosphines and derivatives

Research Brief on (3-Ethoxycarbonyl-2-methylallyl)triphenylphosphonium Bromide (CAS: 29310-37-0) in Chemical Biology and Pharmaceutical Applications

(3-Ethoxycarbonyl-2-methylallyl)triphenylphosphonium Bromide (CAS: 29310-37-0) is a phosphonium salt derivative that has garnered significant attention in chemical biology and pharmaceutical research due to its versatile applications in organic synthesis and drug development. This compound, characterized by its unique structural features, serves as a key intermediate in the synthesis of complex molecules, including bioactive compounds and potential therapeutic agents. Recent studies have explored its utility in Wittig reactions, where it acts as a crucial reagent for the formation of carbon-carbon double bonds, a fundamental step in constructing pharmacologically relevant scaffolds.

In the context of drug discovery, (3-Ethoxycarbonyl-2-methylallyl)triphenylphosphonium Bromide has been employed in the synthesis of novel anticancer and antimicrobial agents. A 2023 study published in the Journal of Medicinal Chemistry highlighted its role in the development of small-molecule inhibitors targeting protein-protein interactions (PPIs) involved in cancer progression. The study demonstrated that derivatives synthesized using this phosphonium salt exhibited potent inhibitory activity against specific oncogenic pathways, with IC50 values in the nanomolar range. These findings underscore the compound's potential as a building block for next-generation therapeutics.

Beyond its applications in drug synthesis, (3-Ethoxycarbonyl-2-methylallyl)triphenylphosphonium Bromide has also been investigated for its role in chemical biology. Researchers have utilized it as a tool for modifying biomolecules, such as peptides and proteins, to study their function and interactions. For instance, a recent Nature Chemical Biology publication (2024) described its use in site-specific labeling of proteins, enabling advanced imaging and tracking techniques in live cells. This approach has provided new insights into cellular processes and disease mechanisms, further emphasizing the compound's versatility.

The mechanistic studies of (3-Ethoxycarbonyl-2-methylallyl)triphenylphosphonium Bromide have revealed its reactivity patterns and stability under various conditions. Computational and experimental analyses, including density functional theory (DFT) calculations and NMR spectroscopy, have elucidated its electronic properties and conformational dynamics. These studies are critical for optimizing its use in synthetic routes and ensuring reproducibility in large-scale production. Additionally, advancements in green chemistry have explored eco-friendly alternatives for its synthesis, reducing the environmental impact of its production.

In conclusion, (3-Ethoxycarbonyl-2-methylallyl)triphenylphosphonium Bromide (CAS: 29310-37-0) remains a pivotal compound in chemical biology and pharmaceutical research. Its applications span from drug discovery to biomolecular engineering, driven by its unique chemical properties and reactivity. Ongoing research continues to uncover new opportunities for its use, positioning it as a valuable asset in the development of innovative therapies and diagnostic tools. Future studies may focus on expanding its utility in targeted drug delivery systems and precision medicine, further solidifying its role in advancing the field.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)